Genetic sequencing has revolutionized clinical diagnostics, offering insights into the genetic basis of diseases. It enables precise identification of genetic mutations and variants, paving the way for personalized medicine. The field has progressed from Sanger sequencing to next-generation sequencing (NGS) and long-read sequencing (LRS). This article explores genetic sequencing techniques for rare disorders, their applications, challenges faced by diagnostic labs, and future prospects.
Methodologies of Genetic Sequencing
Sanger Sequencing:
This first-generation sequencing method involves the selective incorporation of chain-terminating dideoxynucleotides during DNA replication. Although highly accurate, it is labor-intensive and suitable for sequencing small DNA fragments. Sanger sequencing is now routinely used for targeted testing of genetic variants as a validation tool, owing to its high sensitivity and specificity.
Next-Generation Sequencing:
NGS technologies have revolutionized genetic sequencing by allowing the simultaneous sequencing of millions of DNA fragments. This high-throughput approach significantly reduces the time and cost of sequencing, making it feasible to sequence entire genomes or exomes. NGS includes various commercial techniques, such as Illumina’s sequencing-by-synthesis and Thermo Fisher’s Ion Torrent, that revolutionize genetic research and clinical diagnostics. Short-read sequencing (SRS), commonly used in NGS, sequences DNA in the order of 100–300 base pairs (bp). Illumina’s platforms dominate the market, offering capabilities for whole exome sequencing (WES) and whole genome sequencing (WGS).
Figure: Genome sequencing process (PMID: 34697096)
Whole Genome Sequencing (WGS):
WGS sequences the entire genome, providing comprehensive genetic information. It is particularly useful for identifying rare and novel variants that may be missed by exome sequencing or targeted approaches. Non-coding regions are gaining attention for their involvement in disease biology, making WGS increasingly valuable for higher diagnostic yield.
Whole Exome Sequencing (WES):
WES focuses on sequencing the exons, which constitute 1-2% of the genome. It has been pivotal in rare disease diagnostics since most known disease-causing mutations are located in exons. WES offers a cost-effective alternative to WGS for clinical diagnostics.
Long-Read Sequencing (LRS):
While SRS-based NGS has technical limitations in resolving certain variants, LRS can generate sequence reads of tens of thousands of bases, overcoming these challenges. LRS reveals poorly characterized genomic regions such as repeat arrays and structural variants. LRS is primarily conducted using Pacific Biosciences’ (PacBio) SMRT sequencing or Oxford Nanopore Technologies’ (ONT) nanopore sequencing. LRS has been successfully applied in diagnosing genetic disorders such as Fragile X syndrome, Gitelman syndrome, and Werner syndrome.
Significance of Accurate Genetic Sequencing
Personalized Medicine:
Genetic sequencing allows for customized medical treatments based on an individual’s genetic profile. Clinicians can target the root cause of a disease by identifying specific mutations, increasing treatment efficacy and reducing adverse effects. Pharmacogenomics uses genetic information to optimize drug therapies, such as warfarin dosing guided by CYP2C9 and VKORC1 gene variants.
Early Diagnosis and Prevention:
Accurate sequencing enables early detection of genetic predispositions, allowing for preventive measures. For example, mutations in BRCA1 and BRCA2 genes are linked to an increased risk of breast and ovarian cancer, prompting early intervention.
Informed Family Planning:
Genetic sequencing helps prospective parents assess the risk of passing on genetic disorders. Carrier screening for conditions like cystic fibrosis or sickle cell anemia provides valuable information for family planning.
Applications in Clinical Diagnosis
Cancer Genomics:
Genetic sequencing plays a vital role in oncology by identifying somatic mutations in tumors. This guides targeted therapies and treatment monitoring, such as EGFR gene sequencing in lung cancer.
Inherited Genetic Disorders:
Sequencing is essential for diagnosing monogenic disorders such as cystic fibrosis, muscular dystrophy, and Huntington’s disease. Identifying the specific genetic mutation informs diagnosis and treatment.
Pharmacogenomics:
Genetic sequencing enhances pharmacogenomics by identifying genetic variants that influence drug metabolism and efficacy, allowing for personalized medication regimens.
Rare Disease Diagnosis:
Genetic sequencing is crucial for diagnosing rare diseases caused by genetic mutations. It uncovers the genetic basis of these conditions, leading to targeted therapies.
Future Prospects
Advancements in Sequencing Technologies:
Innovations in sequencing technologies, such as nanopore sequencing and SMRT sequencing, promise increased speed, accuracy, and affordability. LRS studies have shown a 38% diagnostic yield in Mendelian disorders, highlighting its clinical potential.
Integration with Electronic Health Records (EHRs):
Integrating genetic data with EHRs will enhance clinical decision-making and facilitate the routine use of genetic information in healthcare.
Expansion of Genomic Databases:
Diversifying genomic databases will improve genetic variant interpretation and identify population-specific risks. Collaborative efforts like the All of Us Research Program aim to build diverse genomic datasets.
Conclusion
Accurate genetic sequencing is a cornerstone of modern clinical diagnostics, driving personalized medicine. Ongoing innovations in sequencing technologies and data interpretation will continue to enhance its utility in healthcare, advancing precision medicine.
